A special scan to tell tumor regrowth from treatment change in brain tumors
Original title: 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a late stage trial in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests a scan that may show whether a brain tumor has come back.
Who this trial is for. This trial is for people who have surgery for certain brain tumors, mostly meningioma. It tests a scan called 68Ga-DOTATATE PET/MRI.
Where it stands. The trial has not reported results. It is looking at how well the scan spots tumor that is left behind or growing again. It also looks at whether the scan can tell tumor apart from changes caused by surgery or radiation. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If the scan works well, doctors may get a clearer picture after treatment. That could help them tell regrowth from healing tissue. Someone who fits this trial could ask their care team about it.
What it doesn't mean: This does not mean the scan is proven to work. A trial is a test, not care that is known to help. Being in one is not a guarantee of any benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.